Corrigendum to "Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy" [Diab. Res. Clin. Pract. 186 (2022) 109835]
Diabetes Res Clin Pract. 2023 Feb:196:110234.
doi: 10.1016/j.diabres.2022.110234.
Epub 2023 Jan 4.
1 NHMRC Clinical Trials Centre, The University of Sydney, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia.
2 NHMRC Clinical Trials Centre, The University of Sydney, Australia; Centre for Public Health, Queens University, Belfast, Northern Ireland, United Kingdom.
3 NHMRC Clinical Trials Centre, The University of Sydney, Australia.
4 Centre for Public Health, Queens University, Belfast, Northern Ireland, United Kingdom.
5 Department of Medicine, St. Vincent's Hospital Campus, The University of Melbourne, Australia.
6 Department of Ophthalmology, Helsinki University Hospital, University of Helsinki, Finland.
7 Lipid and Diabetes Research Group, Christchurch Hospital, Christchurch, New Zealand.
8 Department of Ophthalmology, Royal Victorian Eye and Ear Hospital, The University of Melbourne, Australia.
9 NHMRC Clinical Trials Centre, The University of Sydney, Australia; Centre for Public Health, Queens University, Belfast, Northern Ireland, United Kingdom; Department of Medicine, St. Vincent's Hospital Campus, The University of Melbourne, Australia. Electronic address: Alicia.Jenkins@sydney.edu.au.